Stroke is one of the most dangerous and common complications for patients with atrial fibrillation. Using anticoagulants and changing lifestyle habits have been found to be effective in preventing the risk of stroke in patients with atrial fibrillation.

Vitamin K antagonists are one of the indicated measures in atrial fibrillation. However, this method is still quite vague, especially for patients. Let's learn more about vitamin K antagonists, what are the effects of vitamin K antagonists in atrial fibrillation.

The French ANSM drug regulatory agency said that the use of vitamin K antagonists is contraindicated in pregnant women. In case the patient is still prescribed during pregnancy, the patient must be aware of the risks. In the article below, let's learn about the use of vitamin K antagonists in pregnant women.

Anticoagulants are often prescribed for patients with thrombosis, especially coronary thrombosis. Anticoagulants include antiplatelet drugs and vitamin K antagonists. Accordingly, vitamin K can be dangerous for people taking anticoagulants. Therefore, it is necessary to balance the amount of vitamin K intake and the dosage of the drug.

Coronary stenting is a procedure to help relieve angina pain and reduce the risk of myocardial infarction for patients. To avoid unpredictable complications, patients need to use anticoagulants after stenting. So how should coronary intervention patients with atrial fibrillation use anticoagulants to limit complications?

Anticoagulants play a central role in the treatment of deep vein thrombosis of the lower extremities. The aim of anticoagulation is to prevent recurrent thrombosis, embolism, and death, which are most likely to occur during the first 3 to 6 months after diagnosis.